相关实验视频
Updated: Feb 14, 2026

05:57
Fixation and Operational Method for Abdominal Massage in T2DM Mice
Published on: March 7, 2025
799
喘和T2DM疗法之间的药理相互作用:临床和代谢影响
Maria Gabriella Matera1, Clive Page2, Luigino Calzetta3
1Unit of Pharmacology, Department of Experimental Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Expert opinion on drug metabolism & toxicology
|February 13, 2026
概括
喘和2型糖尿病的治疗方法可以相互影响. 皮质类固醇会恶化血糖,而一些糖尿病药物可以改善喘控制,需要仔细,个性化的患者管理.
科学领域:
- 免疫代谢过程中的免疫代谢.
- 药理学 药理学是指药理学的学科.
- 内分泌学 在内分泌学.
背景情况:
- 喘和2型糖尿病 (T2DM) 经常同时存在.
- 共同的免疫代谢途径将这些疾病联系在一起.
- 一种疾病的药物疗法可能会影响另一种疾病.
研究的目的:
- 审查喘和T2DM治疗之间的双向药理相互作用.
- 检查喘药物的代谢作用和降血糖剂的肺部作用.
- 要突出机械联系,临床影响和表型特异性考虑.
主要方法:
- 现有文献的叙述性审查.
- 综合有关药物相互作用的证据.
- 专注于机械学和临床数据.
主要成果:
- 系统性和高剂量的吸入性皮质类固醇会增加胰岛素抵抗性和高血糖症.
- β2-激动剂可以急剧提高葡萄糖水平;白血抗体和LAMA具有最小的代谢影响.
- 生物制剂通过降低类固醇来帮助代谢控制;甲型胺,GLP-1RA和SGLT2抑制剂对喘有好处.
- 胰岛素可能会加剧呼吸道过敏反应.
结论:
- 临床医生必须仔细管理喘和T2DM治疗之间的药物相互作用.
- 需要特定于表型的综合方法,特别是在与肥胖相关的喘中.
- 需要进一步的基于证据的指导,以获得最佳的患者护理.
相关概念视频
What is Metabolism?
132.6K
Overview
132.6K
Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-III: Symptoms and Complications
3.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.4K
Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Asthma: Pathogenesis and Management
1.4K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K
Asthma-II: Pathophysiology and Classification
4.5K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.5K

